z-logo
open-access-imgOpen Access
COVID-19: A Risk Assessment Perspective
Author(s) -
Imke Schröder
Publication year - 2020
Publication title -
acs chemical health and safety
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.249
H-Index - 21
eISSN - 1878-0504
pISSN - 1871-5532
DOI - 10.1021/acs.chas.0c00035
Subject(s) - covid-19 , pandemic , outbreak , case fatality rate , coronavirus , public health , risk assessment , china , perspective (graphical) , virology , betacoronavirus , disease , environmental health , geography , medicine , infectious disease (medical specialty) , computer science , pathology , population , computer security , archaeology , artificial intelligence
COVID-19 is a newly emerging viral respiratory disease first identified in Wuhan, China, in December 2019. The disease is caused by the coronavirus SARS-CoV-2, which is related to the viruses that cause SARS and MERS. While the case fatality ratio for COVID-19 (5%) is far lower than that for SARS (11%) and MERS (34%), COVID-19 is spreading relatively uncontrolled at this time across the globe. In contrast, SARS appears to be contained, and MERS is controlled. This paper will explore why COVID-19 is able to progress to a global pandemic that affects our daily lives to an extent not known in recent history. The COVID-19 outbreak and spread will be examined based on the current literature, using a researcher's perspective of risk assessment and risk mitigation; this approach will be related to public health.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom